| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5B | $6.8B | $6.2B | $6.4B | $5.8B | $5.1B | $5.0B | $4.8B |
| Cost of Revenue | $5.3B | $4.9B | $4.5B | $4.6B | $4.3B | $3.8B | $3.8B | $3.5B |
| Gross Profit | $2.2B | $1.9B | $1.7B | $1.8B | $1.6B | $0.4B | $0.3B | $0.3B |
| R&D Expense | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | — | — | — |
| SG&A Expense | $1.3B | $1.1B | $1.0B | $1.0B | $0.9B | $1.0B | $0.9B | $0.9B |
| Operating Income | $0.6B | $0.5B | $0.5B | $0.6B | $0.6B | $0.3B | $0.3B | $0.5B |
| Net Income | $-0.5B | $0.1B | $0.2B | $0.3B | $0.2B | $0.1B | $-0.0B | $0.0B |
| EPS (Basic) | $-3.77 | $0.62 | $1.43 | $1.94 | $1.68 | $0.45 | $-0.07 | $0.13 |
| EPS (Diluted) | $-3.77 | $0.61 | $1.42 | $1.90 | $1.63 | $0.44 | $-0.07 | $0.13 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $8.2B | $6.6B | $6.4B | $5.9B | $5.6B | $5.1B | $5.0B |
| Current Assets | $3.4B | $3.2B | $2.7B | $2.5B | $2.5B | $2.2B | $1.8B | $1.8B |
| Cash & Equivalents | $0.7B | $0.7B | $0.6B | $0.3B | $0.8B | $0.5B | $0.1B | $0.3B |
| Total Liabilities | $5.5B | $4.9B | $3.9B | $3.9B | — | — | — | — |
| Current Liabilities | $1.8B | $1.8B | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B |
| Stockholders' Equity | $2.9B | $3.3B | $2.7B | $2.5B | $2.3B | $2.0B | $1.6B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-1.1B | $0.4B | $0.4B | $0.2B | $0.3B | $0.2B | $0.0B | $0.5B |
| Investing Cash Flow | $-0.0B | $-1.4B | $-0.0B | $-0.8B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | — | — | — | $0.1B |
| Financing Cash Flow | $1.1B | $1.0B | $-0.1B | $0.2B | $0.0B | $0.3B | $-0.1B | $-0.2B |